期刊文献+

rTNSALP-FcD10重组表达质粒的构建及在CHO-K1细胞的稳定表达

Construction of recombinant plasmid rTNSALP-FcD10 and its stable expression in CHO cells
原文传递
导出
摘要 目的构建重组表达质粒pcDNA3. 1-rTNSALP-FcD10及p EF1-rTNSALP-FcD10,获得能够稳定表达rTNSALP-FcD10蛋白的CHO-K1细胞株。方法去除重组人非组织特异碱性磷酸酶(tissue-nonspecific alkaline phosphatase,TNSALP)多钛链C端氨基酸连接IgG1的Fc片段及10个天冬氨酸,构建目的基因rhALP-FcD10,将基因分别克隆至pcDNA3. 1及p EF1/Myc-His B载体上,均转化E. coli DH5α细胞;将签定正确的两组重组质粒均转染CHO-K1细胞,进行G418压力筛选,建立稳定转染的CHO-K1细胞系,采用RT-qPCR及Western blot方法检测细胞中rTNSALPFcD10 mRNA转录水平及蛋白表达量。结果重组质粒pcDNA3. 1-rTNSALP-FcD10及pEF1-rTNSALP-FcD10经双酶切鉴定证明构建正确;G418最低致死浓度确定为800μg/m L;CHO-K1细胞中rTNSALP-FcD10 m RNA转录及蛋白水平均高于空白对照组,差异均有统计学意义(P <0. 01);转染p EF1-rTNSALP-FcD10组的蛋白表达量较转染pcDNA3. 1-rTNSALP-FcD10组高。结论成功构建了rTNSALP-FcD10的重组表达质粒pcDNA3. 1-rTNSALP-FcD10及pEF1-rTNSALP-FcD10,获得了稳定转染的CHO-K1细胞系,成功表达目的蛋白rTNSALP-FcD10,为蛋白进一步纯化奠定了良好的实验基础。 Objective To construct recombinant plasmids pcDNA3.1-rTNSALP-FcD10 and p EF1-rTNSALP-FcD10 so as to obtain the CHO-K1 cell line for stable expression of recombinant tissue-nonspecific alkaline phosphatase(rTNSALP).Methods After deletion of amino acids at N-terminus,TNSALP molecules were linked to IgG1-Fc and ten aspartic acid residues,and the constructed target gene rh ALP-FcD10 was cloned into expression vectors pcDNA3.1 and pEF1/MycHis B respectively. Both the recombinant plasmids constructed correctly as proved by restriction analysis and sequencing were transfected to CHO-K1 cells for pressure screening of stable CHO-K1 cell lines with G418. The m RNA transcription and protein expression levels of r TNSALP-FcD10 in the cells were determined by RT-qPCR and Western blot respectively.Results Restriction analysis showed that recombinant plasmids pcDNA3. 1-rTNSALP-FcD10 and pEF1-rTNSALP-FcD10 were constructed correctly. The minimum lethal concentration of G418 was 800 μg/m L. Both the mRNA transcription and protein expression levels of rTNSALP-FcD10 in CHO-K1 cells transfected with the two plasmids were significantly higher than those in blank control group(each P < 0. 01). However,the protein expression level in cells transfected with p EF1-rTNSALP-FcD10 was higher than that with pcDNA3.1-rTNSALP-FcD10. Conclusion Recombinant plasmids pcDNA3. 1-rTNSALP-FcD10 and pEF1-rTNSALP-FcD10 were correctly constructed,while the stably transfected CHO-K 1 cell line was established,and the target protein r TNSALP-FcD10 was successfully expressed,which provided an experimental basis for further purification of the protein.
作者 徐颖 付加芳 唐超 韩金祥 王世立 XU Ying;FU Jia-fang;TANG Chao;HAN Jin-xiang;WANG Shi-li(College of Medicine and Life Science, Shandong Academy of Medical Science,Jinan University, Jinan 250022, Shandong Province, China)
出处 《中国生物制品学杂志》 CAS CSCD 2019年第5期521-526,共6页 Chinese Journal of Biologicals
关键词 重组人非组织特异碱性磷酸酶 CHO-K1细胞 转染 稳定表达 Recombinant human tissue-nonspecific alkaline phosphatase CHO-K1 cells Transfection Stable expression
  • 相关文献

参考文献3

二级参考文献30

  • 1顾吉晋,邓英杰.骨靶向性药物及载体的研究进展[J].中国药剂学杂志(网络版),2009(3):191-197. 被引量:6
  • 2刘鹏,张昱,郭丽.L-天冬氨酸六肽-布洛芬的合成[J].华西药学杂志,2007,22(1):49-50. 被引量:8
  • 3Pierce William M Jr,Waite Leonard C.Bone targeted inhibitors of carbonic anhydrase:EP,201057[P].1986-11-12.
  • 4Kasugai S,Fujisawa R,Waki Y,et al.Selective drug delivery system to bone:small peptide (Asp)6 conjugation[J].J Bone Miner Res,2000,15(5):936 -943.
  • 5Sekido T,Sakura N,Higashi Y,et al.Novel drug delivery system to bone using acidic oligopeptide:pharmacokinetic characteristics and pharmacological potential[J].J Drug Target,2001,9(2):111-121.
  • 6Utina WH,Archer DF,Bachmann GA,et al.Estrogen and progestogen use in postmenopausal women:July 2008 position statement of The North American Menopause Society[J].Menopause,2008,15(4 Pt 1):584 -602.
  • 7Yokogawa K,Miya K,Sekido T,et al.Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice[J].Endocrinology,2001,142(3):1228-1233.
  • 8Joosten U,Joist A,Gosheger G,et al.Effectiveness of hydroxyapatite -vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis[J].Biomaterials,2005,26 (25):5251-5258.
  • 9Takahashi T,Yokogawa K,Sakura N,et al.Bone-targeting of quinolones conjugated with an acidic qligopeptide[J].Pharm Res,2008,25(12):2881 -2888.
  • 10Fraimow HS.Systemic antimicrobial therapy in osteomyelitis[J].Semin Plast Surg,2009,23 (2):90-99.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部